Macular Degeneration Treatment Market Size is Projected to Reach USD 18.59 Billion by 2033, Growing at a CAGR of 7.06%: Straits Research
The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...
The American Journal of Managed Care5d
Resveratrol Oral Supplement Associated With Lower Rates of Intravitreal Aflibercept Injections
Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...
Too Old to Operate4d
Macular Oxygen Saturation and SCP Vascular Density in Diabetic Retinopathy
The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...
ophthalmologytimes8d
Premature birth associated with lifelong changes in retinal structure and vascularity
The investigators found that the premature births to be associated with vascular changes on ocular coherence ...
Macular Degeneration Treatment Market Size, Top Share, Forecast To 2033
Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...
Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)
WALTHAM, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for the every-other-month ...
Australia’s TGA approves Apellis’ SYFOVRE for GA related to AMD
Pharmaceuticals announced that the Therapeutic Goods Administration, TGA, has approved SYFOVRE or pegcetacoplan, for the ...
Finanznachrichten8d
Apellis Pharmaceuticals, Inc.: Apellis Receives Approval of SYFOVRE (pegcetacoplan) in Australia for Geographic Atrophy (GA)
secondary to age-related macular degeneration (AMD) with an intact fovea and when central vision is threatened by GA lesion growth. SYFOVRE is the first and only approved treatment for GA in Australia ...
Healio20d
Study evaluates visual function, OCTA in eyes with PDR, macular capillary nonperfusion
OCT angiography can measure changes in the foveal avascular zone (FAZ) area. FAZ area deteriorated in stable eyes with proliferative diabetic retinopathy and macular capillary nonperfusion.